Expression modes of interferon-α inducible genes in sensitive and resistant human melanoma cells stimulated with regular and pegylated interferon-α

Gene

Volumn 315, Issue 1-2, 2003, Pages 79-86

  Certa, Ulrich ^a   Wilhelm Seiler, Monika ^a   Foser, Stefan ^a   Broger, Clemens ^a   Neeb, Martin ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Expression mode; Gene induction; Gene regulation; Hierarchical clustering; IFN ; Interferon; Interferon resistance; Interferon alpha therapy; Kinetics; Melanoma; Microarrays; Pegylation; Resistance; Skin cancer

Indexed keywords

MESSENGER RNA; PEGINTERFERON ALPHA2A; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERFERON PRIMARY RESPONSE GENE; INTERFERON PRODUCTION; INTERFERON SECONDARY RESPONSE GENE; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 0141594751     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(03)00722-4     Document Type: Article

References (22)

1. Baker D.E. Pegylated interferons. Rev. Gastroenterol. Disord. 1:2001;87-99.
2. Certa U., Seiler M., Padovan E., Spagnoli G.C. High density oligonucleotide array analysis of interferon-alpha2a sensitivity and transcriptional response in melanoma cells. Br. J. Cancer. 85:2001;107-114.
3. Cornil I., Theodorescu D., Man S., Herlyn M., Jambrosic J., Kerbel R.S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6028-6032.
4. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15623-15628.
5. de Veer M.J., Sim H., Whisstock J.C., Devenish R.J., Ralph S.J. IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics. 54:1998;267-277.
6. Halaban R. Growth factors and melanomas. Semin. Oncol. 23:1996;673-681.
7. Kaiser R.G.G. Elementare Tests zur Beurteilung von Messdaten. 1972;Bibliographisches Institut, Mannheim Wien Zuerich.
8. Kirkwood J.M. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies. Eur. J. Cancer. 34(Suppl. 3):1998;S12-S17.
9. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 285:2002;1-24.
10. Lindgren B.W. Statistical Theory. 4th ed. 1993;Chapman and Hall, London.
11. Moro A., Santos A., Arana M.J., Perea S.E. Activation of the human p27(Kip1) promoter by IFNalpha 2b. Biochem. Biophys. Res. Commun. 269:2000;31-34.
12. Pansky A., Hildebrand P., Fasler-Kan E., Baselgia L., Ketterer S., Beglinger C., Heim M.H. Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int. J. Cancer. 85:2000;720-725.
13. Press W.H., Teukolsky S.A., Vetterling W.T. Numerical Recipes. 1986;Cambridge Univ. Press, Cambridge, UK.
14. Rogge L., Bianchi E., Biffi M., Bono E., Chang S.Y., Alexander H., Santini C., Ferrari G., Sinigaglia L., Seiler M., Neeb M., Mous J., Sinigaglia F., Certa U. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25:2000;96-101.
15. Sachs L. Statistische Auswertungsmethoden. 1969;Springer-Verlag, Berlin.
16. Taniguchi T., Harada H., Lamphier M. Regulation of the interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol. 121:1995;516-520.
17. Ulloa L., Doody J., Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 397:1999;710-713.
18. Vial T., Descotes J. Clinical toxicity of the interferons. Drug Saf. 10:1994;115-150.
19. Vidigal P.G., Germer J.J., Zein N.N. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J. Hepatol. 36:2002;271-277.
20. Verma A., Platanias C.P. Signaling via the interferon-f receptor in chronic myelogenous leukemia cells. Leuk. Lymphoma. 43:2002;703-709.
21. Wathelet M.G., Clauss I.M., Content J., Huez G.A. The IFI-56K and IFI-54K interferon inducible human genes belong to the same gene family. FEBS Lett. 231:1988;164-171.
22. Zhu M., John S., Berg M., Leonard W.J. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFN gamma-mediated signaling. Cell. 96:1999;121-130.